ClinicalTrials.gg
Status unknownNCT02400528Eval-PLHUpdated Mar 27, 2015

Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families

An interventional study of quality of life questionnaires in Paraparesis, Tetraparesis and Hemiparesis, sponsored by Assistance Publique Hopitaux De Marseille. Status unknown at 1 site in France. Open to participants aged 3 Years and older. Per ClinicalTrials.gov, last updated 2015-03-27.

Sponsored by Assistance Publique Hopitaux De Marseille · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Feb 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,200
Allocation
Non-randomized
Ages
3 Years and older
Sex
All
01

Study summary

The studies conducted so far concerning the medical and paramedical cares provided to patients with profound and multiple disabilities (PMD) often show important limitations: samples are too small or very heterogeneous, generally constituted of children only; studies are mainly cross-sectional and retrospective, focusing on very specific issues instead of assessing health and quality of life from a more global perspective… So far, the investigators found no published data from a prospective cohort study involving a representative sample of patients with PMD. The present project aims to set up such a cohort so as to describe for the first time the natural history of French patients with PMD as well as the cares they receive at home or within the different dedicated structures in France. This cohort will also make it possible to identify the factors responsible for differences in the cares patients are provided, the consequences of these differences on their health and their quality of life (and those of their relatives) as well as the evolutions of these data over time. It will then allow for assessing the effectiveness of the French healthcare system to care for patients with PMD as well as building a frame of reference regarding the best cares to provide to these patients.

The primary goal of this study is to identify the determinants of health among patients with PMD.

02

Conditions studied

  • Paraparesis
  • Tetraparesis
  • Hemiparesis
  • Ataxia
  • Neuromuscular Disorders
  • Extrapyramidal Motor Disorders
03

In context

Paraparesis

20 studies on the registry are indexed under Paraparesis; 5 are open to participants now.

This study's planned enrollment of 1,200 is above the median of 38 across 16 interventional studies indexed under Paraparesis.

Browse Paraparesis studies →

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 700 studies on the registry; 144 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age > 3 years old,
  • patient with health insurance,
  • causal brain injury before the age of 3,
  • Intellectual Quotient \< 40 or not assessable,
  • motor disability: paraparesis, tetraparesis, hemiparesis, ataxia, neuromuscular disorders, or extrapyramidal motor disorders,
  • score at the Gross Motor Function Classification System > 3,
  • score at the Functional Independence Measure \< 55.

Exclusion criteria

Exclusion Criteria:

Subject declaring benefit "psychotropic treatment which" significantly alter the reasoning, discernment or judgment.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
1,200 participants (estimated)

Study arms

  • Other
    Patients With Profound and Multiple Disabilities

    Behavioral: quality of life questionnaires

Interventions

  • Behavioralquality of life questionnaires
06

What researchers measure

Primary outcomes

  1. Caregivers quality of life

    Assessment of quality of life from questionnaires,WHOQOL-Bref, Brief-COPE \- Brief-COPE

    Time frame: 36 months

Secondary outcomes

  1. emotional distress and subjective burden of natural caregivers,

    Assessment of quality of life from questionnaires,WHOQOL-Bref * Brief-COPE * CRA

    Time frame: 36 months

  2. burnout of institutional caregivers

    Assessment of quality of life from questionnaires,WHOQOL-Bref * Brief-COPE * MBI

    Time frame: 36 months

07

Study locations

1 of 1 sites recruiting
  • Assistance Publique Hôpitaux de Marseille
    Marseille, 13354, France
    • Urielle DESALBRES, Director · Contact · drci@ap-hm.fr · 04.91.38.27.47
    • Pascal AUQUIER, Professor · Principal investigator
    Recruiting
08

References and documents

Publications

  • Baumstarck K, Loukkal S, El Ouazzani H, Del Duca S, Beltran A, Hamouda I, Rousseau MC. Care trajectories in children with profound intellectual and multiple disabilities/polyhandicap: a cross-sectional study of the French National Cohort. Front Public Health. 2026 Jul 3;14:1873749. doi: 10.3389/fpubh.2026.1873749. eCollection 2026. PubMed 42491094 ↗
  • Rousseau MC, Del-Duca S, Beltran A, Ouazzani HE, Hamouda I, de Villemeur TB, Auquier P; Eval-PLH Group; Baumstarck K. Young adults with PIMD Polyhandicap in pediatric settings a situation more complex than problematic. Sci Rep. 2026 May 26;16(1):23990. doi: 10.1038/s41598-026-51457-3. PubMed 42191771 ↗
  • Baumstarck K, Hamouda I, Iline N, El Ouazzani H, Fouladvand M, Loukkal S, Beltran Anzola A, Del Duca S, Rousseau MC; EVAL-PLH Group. Quality of life among individuals with profound intellectual and multiple disabilities: crossed perspectives of institutional caregivers and parents. Health Qual Life Outcomes. 2025 Oct 6;23(1):96. doi: 10.1186/s12955-025-02434-3. PubMed 41053826 ↗
  • Baumstarck K, Del Duca S, El Ouazzani H, Hamouda I, Beltran Anzola A, Aim MA, Rousseau MC. Increased Life Expectancy of People With Profound Intellectual and Multiple Disabilities: What Does It Change for Parents? J Appl Res Intellect Disabil. 2025 Jan;38(1):e70018. doi: 10.1111/jar.70018. PubMed 39934966 ↗
  • Rousseau MC, Beltran A, Hamouda I, Aim MA, Felce A, Lind K, Khaldi N, El Ouazzani H, Auquier P, de Villemeur TB, Baumstarck K. Impact of caring for patients with polyhandicap on institutional health care workers' quality of life: a cross-sectional and longitudinal evaluation. Front Public Health. 2024 Oct 18;12:1427289. doi: 10.3389/fpubh.2024.1427289. eCollection 2024. PubMed 39494083 ↗
  • Baumstarck K, Hamouda I, Aim MA, Anzola AB, Khaldi-Cherif S, Felce A, Maincent K, Lind K, Auquier P, Billette de Villemeur T, Rousseau MC; and the EVAL-P. L. H. Group. Health care management adequacy among French persons with severe profound intellectual and multiple disabilities: a longitudinal study. BMC Health Serv Res. 2024 Jan 18;24(1):99. doi: 10.1186/s12913-024-10552-9. PubMed 38238747 ↗
  • Hamouda I, Rousseau MC, Beltran Anzola A, Aim MA, de Villemeur TB, Auquier P, Baumstarck K; EVAL-PLH group. The French EVAL-PLH cohort of persons with polyhandicap. Sci Rep. 2022 Jul 22;12(1):12512. doi: 10.1038/s41598-022-16596-3. PubMed 35869128 ↗
  • Rousseau MC, Baumstarck K, Valkov M, Felce A, Brisse C, Khaldi-Cherif S, Loundou A, Auquier P, Billette de Villemeur T; French Polyhandicap Group. Impact of severe polyhandicap cared for at home on French informal caregivers' burden: a cross-sectional study. BMJ Open. 2020 Feb 2;10(1):e032257. doi: 10.1136/bmjopen-2019-032257. PubMed 32014871 ↗
  • Rousseau MC, Billette de Villemeur T, Khaldi-Cherif S, Brisse C, Felce A, Baumstarck K, Auquier P; French Polyhandicap Group. Adequacy of care management of patients with polyhandicap in the French health system: A study of 782 patients. PLoS One. 2018 Jul 6;13(7):e0199986. doi: 10.1371/journal.pone.0199986. eCollection 2018. PubMed 29979745 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02400528
Responsible party
Sponsor
First posted
Mar 27, 2015
Start date
Feb 2015
Primary completion
Feb 2018 (estimated)
Completion
Feb 2019 (estimated)
Last update
Mar 27, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion